Safety and efficacy of pulsed imatinib with or without G-CSF versus continuous imatinib in chronic phase chronic myeloid leukaemia patients at 5 years follow-up.

Gallipoli, Paolo; Stobo, Jon; Heaney, Nicholas; Nicolini, Franck E; Clark, Richard; Wilson, George; Tighe, Jane; McLintock, Lorna; Hughes, Timothy; Michor, Franziska; Paul, James; Drummond, Mark; Holyoake, Tessa L

Safety and efficacy of pulsed imatinib with or without G-CSF versus continuous imatinib in chronic phase chronic myeloid leukaemia patients at 5 years follow-up.

Accepted version

Peer-reviewed

Repository URI

https://www.repository.cam.ac.uk/handle/1810/285902

Repository DOI

https://doi.org/10.17863/CAM.9952

Files

Accepted version (271.79 KB)

Type

Article

Authors

Gallipoli, Paolo

https://orcid.org/0000-0001-7254-2253

Stobo, Jon

Heaney, Nicholas

Nicolini, Franck E

Clark, Richard

Show 5 more

Keywords

BCR-ABL1, chronic myeloid leukaemia, stem cells, therapy, trials, Benzamides, Cell Cycle, Dasatinib, Drug Substitution, Drug Synergism, Follow-Up Studies, Fusion Proteins, bcr-abl, Granulocyte Colony-Stimulating Factor, Humans, Imatinib Mesylate, Leukemia, Myeloid, Chronic-Phase, Piperazines, Protein Kinase Inhibitors, Pulse Therapy, Drug, Pyrimidines, Thiazoles, Treatment Outcome

Journal Title

Br J Haematol

Journal ISSN

0007-1048
1365-2141

Volume Title

163

Publisher

Wiley

Publisher DOI

https://doi.org/10.1111/bjh.12532

Rights

http://www.rioxx.net/licenses/all-rights-reserved

Collections

Cambridge University Research Outputs